ImmunoGen, Inc. Annual Operating Lease, Payments in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ImmunoGen, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2022.
  • ImmunoGen, Inc. Operating Lease, Payments for the quarter ending March 31, 2022 was $1.2M, a 14.3% decline year-over-year.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2022 was $5.3M, unchanged from 2021.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2021 was $5.3M, a 3.64% decline from 2020.
  • ImmunoGen, Inc. annual Operating Lease, Payments for 2020 was $5.5M, a 3.77% increase from 2019.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $5.3M $0 0% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-01
2021 $5.3M -$200K -3.64% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $5.5M +$200K +3.77% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $5.3M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.